Shunsuke Ebara

512 citations
15 papers · 325 indexed · h-index 7
Topics
Cancer-related Molecular Pathways (5 papers)RNA modifications and cancer (4 papers)Ubiquitin and proteasome pathways (4 papers)
Partner nations
JapanUnited States

In The Last Decade

Shunsuke Ebara

11 papers receiving 323 citations

Peers

Shunsuke Ebara
Comparison fields: 5 of 62
  • Molecular Biology 208
  • Cancer Research 88
  • Oncology 68
  • Cell Biology 65
  • Pulmonary and Respiratory Medicine 31
Replace Ryan H. Livengood with:
Ryan H. Livengood United States
Blandine Deux France
Irene García‐Palmero Spain
Patrick P.S. Leung United States
Yitao Wang China
Katharina Rothe Canada
Weizhi Xu China
Enkhjargal Batmunkh Hungary
Zuzana Pernicová Czechia
Miro Viitala Finland
Shunsuke Ebara relative to Ryan H. Livengood United States Ryan H. Livengood's profile →
Citations per field
00.5×1.5×2.3×
Ryan H. Livengood · 1×
Citations per year

Countries citing papers authored by Shunsuke Ebara

Since Specialization
Citations

This map shows the geographic impact of Shunsuke Ebara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shunsuke Ebara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shunsuke Ebara more than expected).

Fields of papers citing papers by Shunsuke Ebara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shunsuke Ebara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shunsuke Ebara. The network helps show where Shunsuke Ebara may publish in the future.

Co-authorship network of co-authors of Shunsuke Ebara

This figure shows the co-authorship network connecting the top 25 collaborators of Shunsuke Ebara. A scholar is included among the top collaborators of Shunsuke Ebara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shunsuke Ebara. Shunsuke Ebara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 0
5 1
6 1
7 1
8 15
9 31
10 110
11 18
12 63
13 26
14 2
15 57

About Shunsuke Ebara

Shunsuke Ebara is a scholar working on Oncology, Molecular Biology and Immunology and Allergy, having authored 15 papers that have together received 325 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (5 papers), RNA modifications and cancer (4 papers) and Ubiquitin and proteasome pathways (4 papers). The work is most often cited by research in Cancer Research (88 citations), Cell Biology (65 citations) and Immunology and Allergy (19 citations). Shunsuke Ebara has collaborated with scholars based in Japan and United States. Frequent co-authors include Takahito Hara, Yoshinori Satomi, Ayumi Ando, Saomi Murai, Akito Hata, Megumi Hirayama, Akito Nakamura, Glyn D. Palmer, Wilmot B. Valhmu and Jan‐Fang Cheng. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026